se of Steroid inhalers in COVID.
- Conditions
- Health Condition 1: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/05/033817
- Lead Sponsor
- YOU BREATHE WE CARE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Participant is willing and able to give informed consent
2.Male or Female aged 18 years or above
3.New onset of symptoms suggestive of COVID19 like new onset cough fever, loss of smell or taste within 7 or fewer days of participant being seen at visit 1
4.Able and willing to comply with all trial requirements as per Investigator
1.A known allergy to IMP
2. Any known contraindication to IMP
3. Patient currently prescribed inhaled or systemic corticosteroids
4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids
5. Patient needs hospitalisation at time of study consent
6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial.
7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method